The molecular genetics of cognition: dopamine, COMT and BDNF
暂无分享,去创建一个
[1] J. Hauser,et al. Polymorphism of the brain-derived neurotrophic factor gene and performance on a cognitive prefrontal test in bipolar patients. , 2003, Bipolar disorders.
[2] A. Diamond,et al. Genetic and neurochemical modulation of prefrontal cognitive functions in children. , 2004, The American journal of psychiatry.
[3] T. Robbins,et al. Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. , 2001, Cerebral cortex.
[4] J. Siuciak,et al. BDNF increases monoaminergic activity in rat brain following intracerebroventricular or intraparenchymal administration , 1996, Brain Research.
[5] E. Carbone,et al. BDNF up‐regulates evoked GABAergic transmission in developing hippocampus by potentiating presynaptic N‐ and P/Q‐type Ca2+ channels signalling , 2002, The European journal of neuroscience.
[6] K. Lesch,et al. Serotonin transporter function is modulated by brain-derived neurotrophic factor (BDNF) but not nerve growth factor (NGF) , 2000, Neurochemistry International.
[7] J. Lieberman,et al. Neurocognitive correlates of the COMT Val158Met polymorphism in chronic schizophrenia , 2002, Biological Psychiatry.
[8] R. Barkley. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. , 1997, Psychological bulletin.
[9] P. Goldman-Rakic. Cellular basis of working memory , 1995, Neuron.
[10] F. Previc. Dopamine and the Origins of Human Intelligence , 1999, Brain and Cognition.
[11] Dopamine DRD2 Taq I polymorphism associates with caudate nucleus volume and cognitive performance in memory impaired subjects , 2002, Neuroreport.
[12] L. Zhang,et al. Impairments in High-Frequency Transmission, Synaptic Vesicle Docking, and Synaptic Protein Distribution in the Hippocampus of BDNF Knockout Mice , 1999, The Journal of Neuroscience.
[13] S. Tsai,et al. Association Study of a Brain-Derived Neurotrophic Factor (BDNF) Val66Met Polymorphism and Personality Trait and Intelligence in Healthy Young Females , 2004, Neuropsychobiology.
[14] Bruce F. Pennington,et al. A normative‐developmental study of executive function: A window on prefrontal function in children , 1991 .
[15] G. Mcclearn,et al. No Association Between General Cognitive Ability and the A1 Allele of the D2 Dopamine Receptor Gene , 1997, Behavior genetics.
[16] N C Andreasen,et al. Catechol-O-methyl transferase Val158Met gene polymorphism in schizophrenia: working memory, frontal lobe MRI morphology and frontal cerebral blood flow , 2005 .
[17] T. Lehtimäki,et al. Catechol-O-methyltransferase and Monoamine Oxidase A Genotypes and Drug Response to Conventional Neuroleptics in Schizophrenia , 2003, Journal of clinical psychopharmacology.
[18] Rhonda,et al. Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[19] C. Benkelfat,et al. Catechol-O-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test. , 2002, Archives of general psychiatry.
[20] R. Depue,et al. Opposing roles for dopamine and serotonin in the modulation of human spatial working memory functions. , 1998, Cerebral cortex.
[21] J. Panksepp. Affective Neuroscience: The Foundations of Human and Animal Emotions , 1998 .
[22] C. Altar,et al. Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[23] A. Grace,et al. The Catechol-O-Methyltransferase Polymorphism: Relations to the Tonic–Phasic Dopamine Hypothesis and Neuropsychiatric Phenotypes , 2004, Neuropsychopharmacology.
[24] B. Orser,et al. A D2 Class Dopamine Receptor Transactivates a Receptor Tyrosine Kinase to Inhibit NMDA Receptor Transmission , 2002, Neuron.
[25] E P Noble,et al. The DRD2 gene in psychiatric and neurological disorders and its phenotypes. , 2000, Pharmacogenomics.
[26] K. Någren,et al. C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo , 2004, Molecular Psychiatry.
[27] R. Straub,et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[28] R. Joober,et al. Catechol-O-Methyltransferase (COMT) Val108/158 Met polymorphism does not modulate executive function in children with ADHD , 2004, BMC Medical Genetics.
[29] Ping Zhong,et al. Dopamine D4 Receptors Modulate GABAergic Signaling in Pyramidal Neurons of Prefrontal Cortex , 2002, The Journal of Neuroscience.
[30] M. Farah,et al. Effects of bromocriptine on human subjects depend on working memory capacity , 1997, Neuroreport.
[31] H. Hung,et al. The mesolimbic dopaminergic pathway is more resistant than the nigrostriatal dopaminergic pathway to MPTP and MPP+ toxicity: role of BDNF gene expression. , 1996, Brain research. Molecular brain research.
[32] E. Nestler,et al. A molecular and cellular theory of depression. , 1997, Archives of general psychiatry.
[33] T. Inada,et al. Relationship between catechol‐O‐methyltransferase polymorphism and treatment‐resistant schizophrenia , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[34] Tobias Bonhoeffer,et al. Essential Role for TrkB Receptors in Hippocampus-Mediated Learning , 1999, Neuron.
[35] Y. Stern,et al. Intellectual changes in patients with MPTP‐induced parkinsonism , 1985, Neurology.
[36] T. Goldberg,et al. Genes and the parsing of cognitive processes , 2004, Trends in Cognitive Sciences.
[37] Andre Scedrov,et al. Functional polymorphism , 1990 .
[38] Darin D Dougherty,et al. Dopamine transporter density in patients with attention deficit hyperactivity disorder , 1999, The Lancet.
[39] Shih-Jen Tsai,et al. Association study of a functional catechol-O-methyltransferase-gene polymorphism and cognitive function in healthy females , 2003, Neuroscience Letters.
[40] J. Callicott,et al. Interaction of COMT (Val(108/158)Met) genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia. , 2004, The American journal of psychiatry.
[41] M I Posner,et al. Attention deficit/hyperactivity disorder children with a 7-repeat allele of the dopamine receptor D4 gene have extreme behavior but normal performance on critical neuropsychological tests of attention. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[42] D Robinson,et al. Brain-derived neurotrophic factor Val66met polymorphism and volume of the hippocampal formation , 2005, Molecular Psychiatry.
[43] Petti T. Pang,et al. Regulation of late-phase LTP and long-term memory in normal and aging hippocampus: role of secreted proteins tPA and BDNF , 2004, Ageing Research Reviews.
[44] P. Goldman-Rakic,et al. Reversal of antipsychotic-induced working memory deficits by short-term dopamine D1 receptor stimulation. , 2000, Science.
[45] Z. Yao,et al. Deprivation of endogenous brain-derived neurotrophic factor results in impairment of spatial learning and memory in adult rats , 1999, Brain Research.
[46] T. Robbins,et al. Planning ability in Parkinson's disease is influenced by the COMT val158met polymorphism , 2004, Movement disorders : official journal of the Movement Disorder Society.
[47] J. Savitz,et al. Genetic variants implicated in personality: A review of the more promising candidates , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[48] F. Gierski,et al. Cognitive skill learning in healthy older adults after 2 months of double-blind treatment with piribedil , 2004, Psychopharmacology.
[49] T. Bouchard,et al. Genetic and environmental influences on adult intelligence and special mental abilities. , 1998, Human biology.
[50] M. Egan,et al. The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal Function , 2003, Cell.
[51] S. Berman,et al. Reduced visuospatial performance in children with the D2 dopamine receptor A1 allele , 1995, Behavior genetics.
[52] I. Craig,et al. Functional effects of a tandem duplication polymorphism in the 5′flanking region of the DRD4 gene , 2004, Biological Psychiatry.
[53] JaneR . Taylor,et al. Enhancement of Locomotor Activity and Conditioned Reward to Cocaine by Brain-Derived Neurotrophic Factor , 1999, The Journal of Neuroscience.
[54] J. Kwon,et al. Deficits of organizational strategy and visual memory in obsessive-compulsive disorder. , 2004, Neuropsychology.
[55] Muriel Walshe,et al. Association between BDNF val66 met genotype and episodic memory , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[56] M. Owen,et al. No evidence of association between Catechol-O-Methyltransferase (COMT) Val158Met genotype and performance on neuropsychological tasks in children with ADHD: A case-control study , 2004, BMC psychiatry.
[57] J O Rinne,et al. The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers , 1998, Molecular Psychiatry.
[58] T. Insel,et al. The primate neocortex in comparative perspective using magnetic resonance imaging. , 1999, Journal of human evolution.
[59] P. Goldman-Rakic,et al. A role for inhibition in shaping the temporal flow of information in prefrontal cortex , 2002, Nature Neuroscience.
[60] G. Geffen,et al. Genetic Covariance Among Measures of Information Processing Speed, Working Memory, and IQ , 2001, Behavior genetics.
[61] D. Sibley,et al. Spatial learning deficit in dopamine D(1) receptor knockout mice. , 1999, European journal of pharmacology.
[62] R. Coppola,et al. Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. , 2003, Archives of general psychiatry.
[63] M. Egan,et al. Brain-Derived Neurotrophic Factor val66met Polymorphism Affects Human Memory-Related Hippocampal Activity and Predicts Memory Performance , 2003, The Journal of Neuroscience.
[64] J. Swanson,et al. Evidence of positive selection acting at the human dopamine receptor D4 gene locus , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[65] R. Joober,et al. Dopamine genes and attention-deficit hyperactivity disorder: a review. , 2003, Journal of psychiatry & neuroscience : JPN.
[66] A. Saykin,et al. Neuropsychological impairment in borderline personality disorder. , 2004, The Psychiatric clinics of North America.
[67] P. Goldman-Rakic,et al. Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys , 1994, Psychopharmacology.
[68] R. Davidson,et al. Depression: perspectives from affective neuroscience. , 2002, Annual review of psychology.
[69] D. Weinberger,et al. Genes, dopamine and cortical signal-to-noise ratio in schizophrenia , 2004, Trends in Neurosciences.
[70] C. Marsden,et al. Terguride stimulates locomotor activity at 2 months but not 10 months after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of common marmosets. , 1992, European Journal of Pharmacology.
[71] H. Plotkin. Evolution in Mind - An Introduction to Evolutionary Psychology , 1997 .
[72] Y. Samson,et al. The role of dopamine in cognition: evidence from functional imaging studies , 2003, Current opinion in neurology.
[73] M. Narita,et al. Implication of brain-derived neurotrophic factor in the release of dopamine and dopamine-related behaviors induced by methamphetamine , 2003, Neuroscience.
[74] H. E. Rosvold,et al. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. , 1979, Science.
[75] M. Posner,et al. Assessing the molecular genetics of attention networks , 2002, BMC Neuroscience.
[76] D. Glahn,et al. The feasibility of neuropsychological endophenotypes in the search for genes associated with bipolar affective disorder. , 2004, Bipolar disorders.
[77] R. Gibbs,et al. Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[78] S. Tsai,et al. Dopamine D2 Receptor and N-Methyl-D-Aspartate Receptor 2B Subunit Genetic Variants and Intelligence , 2002, Neuropsychobiology.
[79] K. Hikosaka,et al. Differential changes in glutamate concentration in the primate prefrontal cortex during spatial delayed alternation and sensory-guided tasks , 2002, Experimental Brain Research.
[80] M. Egan,et al. Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[81] R. Ebstein,et al. The short DRD4 repeats confer risk to attention deficit hyperactivity disorder in a family-based design and impair performance on a continuous performance test (TOVA) , 2002, Molecular Psychiatry.
[82] T. Robbins,et al. Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET. , 2002, Brain : a journal of neurology.
[83] M. Owen,et al. Association of the dopamine D4 receptor gene 7-repeat allele with neuropsychological test performance of children with ADHD. , 2004, The American journal of psychiatry.
[84] T. Robbins,et al. Impaired set-shifting and dissociable effects on tests of spatial working memory following the dopamine D2 receptor antagonist sulpiride in human volunteers , 2004, Psychopharmacology.
[85] Lars-Göran Nilsson,et al. COMT Gene Polymorphism Is Associated with Declarative Memory in Adulthood and Old Age , 2004, Behavior genetics.
[86] M. Egan,et al. Prefrontal neurons and the genetics of schizophrenia , 2001, Biological Psychiatry.
[87] Bernard Pillon,et al. Cognitive deficits in Parkinson’s disease , 1996, Journal of Neurology.
[88] A. Malhotra,et al. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. , 2002, The American journal of psychiatry.
[89] Mu-ming Poo,et al. Neurotrophins as synaptic modulators , 2001, Nature Reviews Neuroscience.
[90] H. V. Van Tol,et al. Modulation of Intracellular Cyclic AMP Levels by Different Human Dopamine D4 Receptor Variants , 1995, Journal of neurochemistry.
[91] E. Zackai,et al. Effects of a functional COMT polymorphism on prefrontal cognitive function in patients with 22q11.2 deletion syndrome. , 2004, The American journal of psychiatry.
[92] N. Freimer,et al. Association analysis of candidate genes for neuropsychiatric disease: the perpetual campaign. , 2002, Trends in genetics : TIG.
[93] S. Sorbi,et al. Brain-derived neurotrophic factor, apolipoprotein E genetic variants and cognitive performance in Alzheimer’s disease , 2004, Neuroscience Letters.
[94] A. Fiocco,et al. The Role of Cognitive Deficits in the Development of Eating Disorders , 2004, Neuropsychology Review.
[95] P. Goldman-Rakic,et al. Distribution of dopaminergic receptors in the primate cerebral cortex: Quantitative autoradiographic analysis using [3H]raclopride, [3H]spiperone and [3H]SCH23390 , 1991, Neuroscience.
[96] P. Joyce,et al. Association of a duplicated repeat polymorphism in the 5′‐untranslated region of the DRD4 gene with novelty seeking , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[97] Richard Coppola,et al. Effects of Dextroamphetamine on Cognitive Performance and Cortical Activation , 2000, NeuroImage.
[98] L. Fañanás,et al. New evidence of association between COMT gene and prefrontal neurocognitive function in healthy individuals from sibling pairs discordant for psychosis. , 2004, The American journal of psychiatry.
[99] M. Egan,et al. Catechol-O-methyltransferase val108/158met genotype predicts working memory response to antipsychotic medications , 2004, Biological Psychiatry.
[100] A. Meyer-Lindenberg,et al. The Brain-derived Neurotrophic Factor Val66met Polymorphism and Variation in Human Cortical Morphology , 2022 .
[101] M. Gill,et al. The methionine allele of the COMT polymorphism impairs prefrontal cognition in children and adolescents with ADHD , 2005, Experimental Brain Research.
[102] S. Berman,et al. Prolonged P300 latency in children with the D2 dopamine receptor A1 allele. , 1994, American journal of human genetics.
[103] T. Goldberg,et al. Dopaminergic modulation of cortical function in patients with Parkinson's disease , 2002, Annals of neurology.
[104] Robert M Bilder,et al. Catechol O-methyltransferase Val158Met polymorphism in schizophrenia: differential effects of Val and Met alleles on cognitive stability and flexibility. , 2004, The American journal of psychiatry.
[105] J. Tepper,et al. Local infusion of brain-derived neurotrophic factor modifies the firing pattern of dorsal raphé serotonergic neurons , 1996, Brain Research.
[106] Rex E. Jung,et al. Myths of Neuropsychology: Intelligence, Neurometabolism, and Cognitive Ability , 2000, The Clinical neuropsychologist.
[107] Sean A. Spence,et al. Descartes' Error: Emotion, Reason and the Human Brain , 1995 .
[108] T. Robbins,et al. Chemistry of the adaptive mind , 2004, Philosophical Transactions of the Royal Society of London. Series A: Mathematical, Physical and Engineering Sciences.
[109] W. Sturm,et al. Neuropsychological assessment , 2007, Journal of Neurology.
[110] T. Robbins,et al. The BDNF Val66Met polymorphism has a gender specific influence on planning ability in Parkinson’s disease , 2005, Journal of Neurology.
[111] T. Arinami,et al. A genetic polymorphism in the promoter region of DRD4 associated with expression and schizophrenia. , 1999, Biochemical and biophysical research communications.
[112] J. Savitz,et al. Neuropsychological dysfunction in bipolar affective disorder: a critical opinion. , 2005, Bipolar disorders.
[113] Wm. R. Wright. General Intelligence, Objectively Determined and Measured. , 1905 .
[114] S. Segalowitz,et al. Charting the maturation of the frontal lobe: An electrophysiological strategy , 2004, Brain and Cognition.
[115] S. Pollmann,et al. D1- Versus D2-Receptor Modulation of Visuospatial Working Memory in Humans , 1998, The Journal of Neuroscience.
[116] William S. Kremen,et al. Neuropsychology in schizophrenia: an update , 2003 .
[117] M. Iyo,et al. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET , 1997, Nature.
[118] H. Ollat. Dopaminergic insufficiency reflecting cerebral ageing: value of a dopaminergic agonist, piribedil , 1992, Journal of Neurology.
[119] N. Saitou,et al. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. , 2003, Human molecular genetics.
[120] P. Schlattmann,et al. Association of the G1947A COMT (Val108/158Met) gene polymorphism with prefrontal P300 during information processing , 2003, Biological Psychiatry.
[121] C. Stefanis,et al. Variation in catechol-o-methyltransferase val158 met genotype associated with schizotypy but not cognition: A population study in 543 young men , 2004, Biological Psychiatry.
[122] Xueying Jiang,et al. BDNF Variation and Mood Disorders: A Novel Functional Promoter Polymorphism and Val66Met are Associated with Anxiety but Have Opposing Effects , 2005, Neuropsychopharmacology.
[123] V. Kustanovich,et al. Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: confirmation of association of ADHD with DRD4 and DRD5 , 2004, Molecular Psychiatry.
[124] T. Robbins,et al. Systemic sulpiride in young adult volunteers simulates the profile of cognitive deficits in Parkinson’s disease , 1999, Psychopharmacology.
[125] S. Tsai,et al. Association Study of a Functional Catechol-O-Methyltransferase Genetic Polymorphism with Age of Onset, Cognitive Function, Symptomatology and Prognosis in Chronic Schizophrenia , 2004, Neuropsychobiology.
[126] R. Ebstein,et al. Haplotype relative risk study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): association of the high-enzyme activity Val allele with ADHD impulsive-hyperactive phenotype. , 1999, American journal of medical genetics.